MedPath

Hisamitsu Pharmaceutical Co., Inc.

Hisamitsu Pharmaceutical Co., Inc. logo
🇯🇵Japan
Ownership
Public
Established
1847-01-01
Employees
5K
Market Cap
-
Website
http://www.hisamitsu.co.jp

Safety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the Toenail

Phase 2
Completed
Conditions
Onychomycosis
Interventions
Drug: HTU-520 Patch
Other: Placebo Patch
First Posted Date
2011-07-22
Last Posted Date
2015-06-04
Lead Sponsor
Hisamitsu Pharmaceutical Co., Inc.
Target Recruit Count
182
Registration Number
NCT01400594
Locations
🇺🇸

Radiant Research, Inc., San Antonio, Texas, United States

🇺🇸

Florida Academic Dermatology Center, Miami, Florida, United States

🇺🇸

Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, United States

and more 24 locations

FS-67 in the Treatment of Pediatric Patients With Ankle Sprain

Phase 4
Completed
Conditions
Ankle Sprain
Interventions
Drug: FS-67 Patch
Other: Placebo Patch
First Posted Date
2009-12-23
Last Posted Date
2022-10-06
Lead Sponsor
Hisamitsu Pharmaceutical Co., Inc.
Target Recruit Count
252
Registration Number
NCT01037816
Locations
🇺🇸

Hisamitsu Investigator Site, Grapevine, Texas, United States

HKT-500 in the Treatment of Adult Patients With Ankle Sprain

Phase 3
Completed
Conditions
Ankle Sprain
Interventions
Other: Placebo Patch
First Posted Date
2009-06-25
Last Posted Date
2015-06-04
Lead Sponsor
Hisamitsu Pharmaceutical Co., Inc.
Target Recruit Count
240
Registration Number
NCT00927641
Locations
🇺🇸

Hisamitsu Investigator Site, Danville, Virginia, United States

HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain

Phase 3
Completed
Conditions
Osteoarthritis of the Knee
Interventions
Other: Placebo Patch
First Posted Date
2008-11-18
Last Posted Date
2015-06-04
Lead Sponsor
Hisamitsu Pharmaceutical Co., Inc.
Target Recruit Count
380
Registration Number
NCT00792727
Locations
🇺🇸

Hisamitsu Investigator Site, Yakima, Washington, United States

HKT-500 in Adult Patients With Ankle Sprain

Phase 3
Completed
Conditions
Ankle Sprain
Interventions
Drug: HKT-500 Ketoprofen Topical Patch
Other: Placebo Patch
First Posted Date
2008-05-20
Last Posted Date
2015-06-04
Lead Sponsor
Hisamitsu Pharmaceutical Co., Inc.
Target Recruit Count
260
Registration Number
NCT00680784
Locations
🇺🇸

Hisamitsu Investigator Site., Bellevue, Washington, United States

HKT-500 in Adult Patients With Shoulder Pain

Phase 3
Completed
Conditions
Pain
Interventions
Other: Placebo Patch
Drug: HKT-500 Ketoprofen Topical Patch
First Posted Date
2008-05-20
Last Posted Date
2015-06-04
Lead Sponsor
Hisamitsu Pharmaceutical Co., Inc.
Target Recruit Count
368
Registration Number
NCT00680472
Locations
🇺🇸

Hisamitsu Pharmaceutical Co., Inc., Orange City, Florida, United States

🇺🇸

HIsamitsu Pharmaceutical Co., Inc., Perrysburg, Ohio, United States

🇺🇸

Hisamitsu Investigator Site, Newport News, Virginia, United States

HKT-500-US12 In Adult Patients With OA Knee Pain

Phase 2
Completed
Conditions
Osteoarthritis, Knee
Interventions
Drug: HKT-500 Topical Patch
Other: Placebo Patch
First Posted Date
2008-03-31
Last Posted Date
2015-06-04
Lead Sponsor
Hisamitsu Pharmaceutical Co., Inc.
Target Recruit Count
300
Registration Number
NCT00647231
Locations
🇺🇸

Hisamitsu Investigator Site, Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath